Great Lakes Node of the Drug Abuse Clinical Trials Network

药物滥用临床试验网络五大湖节点

基本信息

批准号：
10662573
负责人：
Niranjan Subhash Karnik
金额：
$ 41.6万
依托单位：
UNIVERSITY OF ILLINOIS AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-03-10 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10662573
关键词：
Academic Medical Centers Adolescent African American population Aging Area Artificial Intelligence Asian Buprenorphine Caring Cessation of life Chicago Cities Clinical Trials Clinical Trials Network Collaborations Communities County Data Analytics Distance Education Drug abuse Electronic Health Record Emergency department visit Epidemic Ethnic Origin Federal Government Gender Identity Geography Health Health system Heroin Home Homeless persons Hospitals Illinois Indiana Intervention Latino Learning Life Cycle Stages Los Angeles Mentorship Methods Midwestern United States Minority Modeling Morbidity - disease rate National Institute of Drug Abuse Native Americans Natural Language Processing New York Opioid Opioid Analgesics Pacific Islander Pathway interactions Population Prevention strategy Professional Education Professional Practice Protocols documentation Public Health Race Recommendation Refugees Research Research Methodology Research Personnel Rest Rural Sex Orientation Side System Testing Training Training Support United States National Institutes of Health Universities Veterans Vulnerable Populations Wisconsin Work Youth addiction adolescent health collaborative care cooking digital digital technology eHealth ethnic diversity experience health disparity interest mHealth medical schools metropolitan mobile computing mortality novel opioid misuse opioid overdose opioid treatment program overdose death population health programs racial diversity rural area screening sexual identity socioeconomics substance misuse suburb success telehealth urban area vulnerable community waiver young adult

Academic Medical Centers Adolescent African American population Aging Area Artificial Intelligence Asian Buprenorphine Caring Cessation of life Chicago Cities Clinical Trials Clinical Trials Network Collaborations Communities County Data Analytics Distance Education Drug abuse Electronic Health Record Emergency department visit Epidemic Ethnic Origin Federal Government Gender Identity Geography Health Health system Heroin Home Homeless persons Hospitals Illinois Indiana Intervention Latino Learning Life Cycle Stages Los Angeles Mentorship Methods Midwestern United States Minority Modeling Morbidity - disease rate National Institute of Drug Abuse Native Americans Natural Language Processing New York Opioid Opioid Analgesics Pacific Islander Pathway interactions Population Prevention strategy Professional Education Professional Practice Protocols documentation Public Health Race Recommendation Refugees Research Research Methodology Research Personnel Rest Rural Sex Orientation Side System Testing Training Training Support United States National Institutes of Health Universities Veterans Vulnerable Populations Wisconsin Work Youth addiction adolescent health collaborative care cooking digital digital technology eHealth ethnic diversity experience health disparity interest mHealth medical schools metropolitan mobile computing mortality novel opioid misuse opioid overdose opioid treatment program overdose death population health programs racial diversity rural area screening sexual identity socioeconomics substance misuse suburb success telehealth urban area vulnerable community waiver young adult

展开

项目摘要

Project Summary/Abstract In alignment with RFA-DA-19-008, this application seeks to establish the Great Lakes Node (GLN) of the NIDA-supported Drug Abuse Clinical Trials Network (CTN). This node will draw on an experienced set of investigators who have active collaborations and represent all of the major academic medical centers in the Greater Chicago and Wisconsin areas. The node will serve as a vital Midwestern hub for the CTN and will expand on the success of the CTN approach. In addition, the GLN will bring substantial experience in adolescent/young adult research, seniors/aging research, digital & mobile technologies, opioid misuse, collaborative care/population health, telehealth, and electronic health record and systems-driven interventions and research methodologies. The GLN will support engagement with CTN protocols and also add the following: Aim 1: GLN will identify and recommend substance misuse research and intervention protocols focused on systems-based practice using hospital-based screening, collaborative care, and population approaches. Aim 2: We will establish a digital and computation health core that will leverage our expertise in these domains and serve as a conduit for studies in mHealth, eHealth, artificial intelligence, natural language processing, and telehealth interventions. Aim 3: Our node will bring substantial expertise with youth/adolescent health and seniors/aging that will enable us to recommend studies to the CTN that examine the genesis of substance misuse and the potential for prevention strategies to mitigate these life-course pathways. Aim 4: In alignment with our team’s expertise, we plan to support work on substance and opioid misuse that focuses on health disparities including socioeconomic, geographic, sexual orientation, and gender identity. Aim 5: Leveraging our experience in professional education and practice-based learning, our node will rigorously test the impact of professional education on opioid and substance treatment. We have built on the ECHO model to develop methods to conduct high-quality distance education and supported training that are currently being trialed in Illinois with plans to expand these programs nationally. Aim 6: GLN will expand the pipeline of early investigators interested in substance misuse research. We will align this part of our program with our very successful CTSA-supported programs and build specific subprogramming that supports addiction and substance misuse research, training, and mentorship.

项目摘要/摘要在与RFA-DA-19-008的一致性中，此应用程序旨在建立大湖节点（GLN） NIDA支持的药物滥用临床试验网络（CTN）。该节点将借鉴一组经验丰富的有积极合作并代表所有主要学术医疗中心的调查人员大芝加哥和威斯康星州。该节点将作为CTN的重要中西部集线器扩展CTN方法的成功。此外，GLN将带来丰富的经验青少年/年轻成人研究，老年人/老龄化研究，数字和移动技术，阿片类药物滥用，协作护理/人口健康，远程医疗以及电子健康记录以及系统驱动的干预措施和研究方法。 GLN将支持与CTN协议的参与，并添加以下内容：目标1：GLN将识别并推荐关注的物质研究和干预协议使用基于医院的筛查，协作护理和人口方法的基于系统的实践。目标2：我们将建立一个数字和计算健康核心，该核心将利用我们在这些领域的专业知识并充当MHealth，Ehealth，人工智能，自然语言处理以及远程医疗干预措施。目标3：我们的节点将带来青年/青少年健康和老年人/老年人的大量专业知识美国向CTN推荐研究，以检查物质滥用的起源和潜力预防策略来减轻这些生活方式途径。目标4：为了与团队的专业知识保持一致，我们计划支持有关物质和阿片类药物滥用工作的工作专注于健康分布，包括社会经济，地理，性取向和性别认同。目标5：利用我们在专业教育和基于实践学习方面的经验，我们的节点将严格测试专业教育对阿片类药物和药物治疗的影响。我们已经建立在回声模型，以开发进行高质量远程教育和支持的培训的方法目前正在伊利诺伊州进行试用，并计划在全国范围内扩大这些计划。目标6：GLN将扩大对滥用药物研究感兴趣的早期研究人员的管道。我们将将我们计划的这一部分与我们非常成功的CTSA支持的程序保持一致，并构建特定的支持成瘾和药物滥用研究，培训和精神训练的子编程。